SUGGESTED PRESCRIBED DOSAGE LIST
|
|
|
- Ernest Perkins
- 5 years ago
- Views:
Transcription
1 approved and issued by a noted Authorized User on your Materials License. CENTRAL NERVOUS SYSTEM Brain Metabolism Brain Perfusion Cisternography Ventricular Shunt 18 F-FDG mci ( MBq) 99m Tc ECD 20 mci (740 MBq) 99m Tc HMPAO 20 mci (740 MBq) 111 In DTPA 1.5 mci (55.5 MBq) 99m Tc DTPA 1 mci (30 MBq) CARDIOVASCULAR SYSTEM Angiography Brain & Peripheral Cardiac Blood Pool Rest Lymphoscintrigraphy Myocardial Perfusion Myocardial Perfusion 99m Tc DTPA 25 mci (925 MBq) 99m Tc RBC 25 mci (925 MBq) 99m Tc SC Filtered ( μ) mci ( MBq) 13 N Ammonia 20 mci (740 MBq) 82 Rb Chloride mci ( GBq) Myocardial Perfusion 99m Tc Tetrofosmin 99m Tc Sestamibi 15 / 30 mci ( GBq) 15 / 30 mci ( GBq) Myocardial Viability Perfusion & Viability 18 F FDG mci ( MBq) 201 Tl Chloride 1.5 / 3.0 mci ( MBq) ENDOCRINE Neuroectodermal / Norepinephrine 123 I MIBG 10 mci (370 MBq) 131 I MIBG 1 mci (37 MBq) Parathyroid 99m Tc Sestamibi 25 mci (925 MBq) MPC
2 ENDOCRINE Cont d. Thyroid Imaging Thyroid Imaging Thyroid Metastases 123 I 0.5 mci (18.5 MBq) 99m Tc 5 mci (185 MBq) 123 I 2 mci (74 MBq) 131 I 2 10 mci ( MBq) Thyroid Uptake 123 I 0.1 mci (3.7 MBq) 131 I 0.01 mci (0.37 MBq) GASTROINSTESTINAL Esophageal Transit 99m Tc SC in H 2 O 0.3 mci/15 ml (11.1 MBq) Gastric Emptying 99m Tc SC in Oatmeal 1 mci/pkg (37 MBq) Gastro-Esophageal Reflux 99m Tc SC in Orange Juice 0.3 mci/300 ml (11.1 MBq) Gastrointestinal Bleeding H.Pylori Breath Test Hepatic Artery Perfusion Hepatic Hemangioma Hepato Biliary LeVeen Shunt 99m Tc RBC 25 mci (925 MBq) 14 C Urea mci (0.037 MBq) 99m Tc MAA 3 mci (111 MBq) 99m Tc RBC 25 mci (925 MBq) 99m Tc IDA 6 mci (222 MBq) 99m Tc MAA 5 mci (185 MBq) 99m Tc SC 3 mci (111 MBq) Liver Spleen Meckels Diverticulum 99m Tc SC 6 mci (222 MBq) 99m Tc 5 mci (185 MBq) MPC
3 GENTOURINARY Cystogram 99m Tc 1 mci (37 MBq) 99m Tc SC 1 mci (37 MBq) 99m Tc DTPA 1 mci (37 MBq) Renal DMSA Renal DTPA Renal MAG3 99m Tc DMSA 5 mci (185 MBq) 99m Tc DTPA 15 mci (555 MBq) 99m Tc MAG3 10 mci (370 MBq) HEMATOLOGY Bone Marrow Schilling s Test 99m Tc SC 15 mci (555 MBq) 57 Co Vitamin B mci ( MBq) INFECTION Gallium WBC Activation 67 Ga Citrate 6 10 mci ( MBq) 18 F FDG mci ( MBq) WBC Migration Study 99m Tc WBC HMPAO mci ( MBq) 111 In WBC 0.5 mci (18.5 MBq) PULMONARY Lung Aerosol 99m Tc DTPA Aerosol 6 mci to Pt. (222 MBq) mci to Nebulizer ( GBq) Lung Perfusion Lung Ventilation 99m Tc MAA 6 mci / Xe-133 (222 MBq) 2 mci / before aerosol (74 MBq) 133 Xe Gas 20 mci (740 MBq) MPC
4 PULMONARY cont d. Pulmonary Aspiration 99m Tc SC 0.5 mci / 300 ml Formula 2 mci / 300 ml H 2 O SKELETAL Skeletal F-18 Bone Mineral Study 18 F Chloride mci ( MBq) 99m Tc MDP 25 mci (925 MBq) 99m Tc HMDP 25 mci (925 MBq) TUMOR B-Cell Lymphoma Bexxar 131 I Tositumomab 5 mci (185 MBq) B-Cell Lymphoma-Zevalin 111 In Ibritumomab Tiuxetan 5 mci (185 MBq) Prostate Ca Study Neuroendocrine Tumor 111 In Capromab Pendetide 5 mci (185 MBq) 111 In Pentetreotide 6 mci (222 MBq) Tumor Glucose Metabolism 18 F FDG mci ( MBq) Tumor Viability 201 Tl Chloride 5 mci (185 MBq) 99m Tc Sestamibi 25 mci (925 MBq) 99m Tc Tetrofosmin 25 mci (925 MBq) MPC
5 ENDOCRINE Thyroid Cancer Papillo-follicular 131 I Residual Functioning Tissue Post Thyroidectomy mci ( GBq) 131 I Persistent or Recurrent Functioning Thyroid Ca mci ( GBq) Thyroid Cancer Compressive Goiter 131 I 100 mci (3.7 GBq) Diffuse Hyperthyroidism Nodular Hyperthyroidism 131 I mci ( MBq) 131 I mci ( GBq) HEMATOLOGIC Polycythemia Vera 32 P Sodium Solution 2.3 mci/m 2 (85.1 MBq / m 2 ) INTRACAVITARY Fluid or Neoplasm 32 P Chromic Colloid Pleura mci Peritoneum mci Pericardium 5-10 mci SKELETAL Osseous Metastases Pain 89 Sr Chloride mci / kg 153 Sm EDTMP 1.0 mci / kg Synoviorthesis 32 P Chromic Colloid Knee 1 mci (37 MBq) Elbow 0.5 mci (18.5 MBq) MPC
6 TUMOR B-Cell Lymphoma 90 Y Zevalin 0.4 mci / kg ** (>150,000 platelets/ml) 0.3 mci / kg ** (100K 150K platelets/ml) ** Not to Exceed 32 mci B-Cell Lymphoma 131 I Bexxar MPC
Recent initiatives of the FANC. Michel Biernaux Health Protection Service Health and Environment Department
Recent initiatives of the FANC Michel Biernaux Michel.biernaux@fanc.fgov.be Health Protection Service Health and Environment Department Reminder objectives of the national survey : 1.Review the average
Contrast Agents and Radiopharmaceuticals 2017
Contrast Agents and Radiopharmaceuticals 207 Covered: Code Code Description Allow with Code(s) Code Description Max Units A464 Radiopharmaceutical, diagnostic, not otherwise classified n/a Invoice Req'd
2017 St. Luke's-Roosevelt Nuclear Medicine Department Procedure Catalog. meds
2017 St. Luke's-Roosevelt Nuclear Medicine Department Procedure Catalog Procedure Name Patient Preparation Cardiac Studies Stress Myocardial Perfusion Study Gated pool study (MUGA) Myocardial Cell Damage
Radiopharmaceutical Activities Administered for Diagnostic and Therapeutic Procedures in Nuclear Medicine in Argentine: Results of a National Survey
Radiopharmaceutical Activities Administered for Diagnostic and Therapeutic Procedures in Nuclear Medicine in Argentine: Results of a National Survey A. M. Bomben, C. A. Chiliutti Autoridad Regulatoria
NUCLEAR MEDICINE IN VIVO
PREAMBLE SPECIIC ELEMENTS or acility ee Component ( fee) A. Preparing the patient for the procedure. B. Performing the diagnostic procedure(s). C. Making arrangements for any appropriate follow-up care.
Official Listing of Radioactive Materials Approved for the Four Groups of Diagnostic Uses as Defined in 15A NCAC
Division of Environmental Health Radiation Protection Section Radioactive Materials Branch PUBLICATION 97-01 Official Listing of Radioactive Materials Approved for the Four Groups of Diagnostic Uses as
NUCLEAR MEDICINE APC TASK FORCE
NUCLEAR MEDICINE APC TASK FORCE American College of Nuclear Physicians American Society of Nuclear Cardiology Council on Radionuclides and Radiopharmaceuticals, Inc. Academy of Molecular Imaging Society
RadTool Nuclear Medicine Flash Facts
RadTool Nuclear Medicine Flash Facts Bital Savir-Baruch Bruce J. Barron RadTool Nuclear Medicine Flash Facts Illustrations by Eric Jablonowski Bital Savir-Baruch Loyola University Medical Center Maywood
Overview Therapeutic Radiopharmaceuticals in Nuclear Medicine Definition: Characteristics of the Ideal Therapeutic Radiopharmaceutical
Overview After reviewing this tutorial, the users should be able to list the most important characteristics of the ideal therapeutic radiopharmaceutical and briefly discuss each of these as it relates
RADIOPHARMACEUTICALS AND DRUGS ELIGIBLE FOR CONTINUED SEPARATE MEDICARE PAYMENT ( 2 TO 3 Year Transitional Period )
NUCLEAR MEDICINE APC TASK FORCE American College of Nuclear Physicians American Society of Nuclear Cardiology Council on Radionuclides and Radiopharmaceuticals, Inc. Academy of Molecular Imaging Society
Contributions of Nuclear Isotopes in Medicine, a Perspective
Contributions of Nuclear Isotopes in Medicine, a Perspective February 21, 2012 at American Nuclear Society, CT Section David W. Cheng, MD, PhD Associate Professor of Diagnostic Radiology Chief of Nuclear
Sacred Heart Hospital on the Emerald Coast
- Nuclear Medicine - Regular Hours: 7:30 am 4:30 pm Monday Friday See *1 Scheduling/Orders: Ph. (850) 278-3800 Fax (850) 278-3787 Results: Health Information Mgmt (Med Records) Ph. (850) 278-3020 Contact
Deleted Effective Beginning of Calendar Year Not Paid under Outpatient PPS Not Paid Under OPPS or any other Medicare payment system
FINAL 2010 Compared to FINAL 2011 Rates Medicare Hospital Outpatient Prospective Payment System HOPPS (APC) Nuclear Medicine Procedures, Radiopharmaceuticals, and Drugs CMS Website HOPPS CY2011 FINAL Rule
Department of Nuclear Medicine with Positron Emission Tomography
(PET) Unit [1] Contact information: Registration: +48 41 367 4850 Main office: +48 41 367 4860 Fax: +48 41 367 4887 e-mail: zmnsco@onkol.kielce.pl [2] Head of the Department: Professor Janusz Braziewicz
Radionuclide Therapy: History, Present and Future Promise. History of Radionuclide (RN) Therapy. History of RN Therapy 8/2/2017
Radionuclide Therapy: History, Present and Future Promise Bennett S. Greenspan, MD, MS Professor, Dept. of Radiology, MCG / AU President, SNMMI AAPM Annual Meeting, Denver, CO History Symposium 8/02/2017
Not Paid under Outpatient PPS. Deleted Effective Beginning of Calendar Year Not Paid under Outpatient PPS
Indicator A B Service Services furnished to a hospital outpatient that are paid under a fee schedule or payment system other than OPPS Codes that are not recognized by OPPS when submitted on an Outpatient
Steven G. Marsh MS, DABMP, Medical Health Physics RSO - Baystate Health Springfield, MA
Steven G. Marsh MS, DABMP, Medical Health Physics RSO - Baystate Health Springfield, MA Radioactive Materials License: NRC or Agreement State Broad Scope & Medical Component Limited License Regulations
Release of Patients or Human Research Subjects Administered Radioactive Materials
Release of Patients or Human Research Subjects Administered Radioactive Materials Section (41) (a), "Release of Individuals Containing Radioactive Drugs or Implants," of Chapter 420-3-26 of the Rules published
Excretion Factors: the percentage of administered radioactivity released to sewer for routinely used radiopharmaceuticals.
Institute of Ph ysics and Engineering in M edicine 1. Background ADVICE NOTICE: Excretion Factors: the percentage of administered radioactivity released to sewer for routinely used radiopharmaceuticals.
HEALTHFIRST 2011 RADIOLOGY PROGRAM CODE LIST
HEALTHFIRST 2011 RADIOLOGY PROGRAM CODE LIST Outpatient Radiology utilization call Carecore at 1-877-773-6964 Modality CPT CODE Description CT SCANS 70450 CT HEAD/BRAIN W/O CONTRAST CT SCANS 70460 CT HEAD/BRAIN
Dr Alfred O Ankrah FCNP
Dr Alfred O Ankrah FCNP Outline Introduction Brief history of Nuclear Medicine in Ghana Current situation of Nuclear Medicine in Ghana Use of Nuclear medicine in various disciplines Future of Nuclear Medicine
HIP RADIOLOGY PROGRAM CODE LISTS
EFFECTIVE OCTOBER 1, 2012 70336 MAGNETIC RESONANCE IMAGING TMJ 70450 COMPUTED TOMOGRAPHY HEAD/BRAIN WITHOUT 70460 COMPUTED TOMOGRAPHY HEAD/BRAIN WITH 70470 COMPUTED TOMOGRAPHY HEAD/BRAIN WITHOUT AND WITH
Nuclear Medicine in Australia. Shaun Jenkinson
Nuclear Medicine in Australia Shaun Jenkinson Landmark Infrastructure for Australian Science OPAL Research Reactor Australian Synchrotron Camperdown Cyclotron Bragg Institute Centre for Accelerator Science
Health Concerns Related to Radiation Exposure. of the Female Nuclear Medicine Patient. Michael G. Stabin
Health Concerns Related to Radiation Exposure of the Female Nuclear Medicine Patient Michael G. Stabin Radiation Internal Dose Information Center Oak Ridge Institute for Science and Education P.O. Box
Water Any Inulin IV Normal renal function Inulin IV Abnormal renal function Glucose IV Normal Carfentanil IV 17.
Table 1: Effective Dose Equivalent (HE) values for common procedures involving the use of radiopharmaceuticals. Listings (last column) are averaged over both sexes, and are computed for adult subjects.
Radionuclid Therapy. dr. Erzsébet Schmidt Dept. of Nuclear Medicine University of Pécs
Radionuclid Therapy dr. Erzsébet Schmidt Dept. of Nuclear Medicine University of Pécs Therapy Principle of radionuclid therapy - carrying a cytotoxic agent, such as radionuclid, direct to an aberrant cell
Components of Preparedness
Components of Preparedness Domain I: Radiation Physics & Detection 7% Domain II: Radiation Safety & Regulations 13% Domain III: Pharmaceutical & Radiopharmaceutical Agents 25% Domain IV: Instrument Operations
Section XII Nuclear Radiology
Section XII Nuclear Radiology I-123 thyroid scintigrams Figure 1 235. You are shown I-123 thyroid images (Figure 1) obtained from a 54-year-old woman with signs and symptoms of hyperthyroidism. Which of
Procedure Guidelines. Nuclear Medicine
Procedure Guidelines Nuclear Medicine Dutch Society of Nuclear Medicine Procedure Guidelines Nuclear Medicine Dutch Society of Nuclear Medicine Editor-in-chief: JP Esser I Diagnostic Methods II Radionuclide
2010 Radiology Prior Authorization List for UnitedHealthcare s HealthChoice Members
70336 MR TEMPOROMANDIBULAR JOINT 70450 CT, HEAD OR BRAIN; WITHOUT MATERIAL 70460 CT HEAD/BRAIN W/ 70470 CT HEAD/BRAIN W/O & W/ 70480 CT, ORBIT, SELLA, OR POSTERIOR FOSSA OR OUTER, MID 70481 CT ORBIT W/
Radio-isotopes in Clinical Medicine
Radio-isotopes in Clinical Medicine Radiactive isotopes, whether naturally occurring or artificially produced, have a number of different uses in clinical medicine. These include: (1) Diagnostic and research
Nuclear medicine studies of the digestiv system. Zámbó Katalin Department of Nuclear Medicine
Nuclear medicine studies of the digestiv system Zámbó Katalin Department of Nuclear Medicine Anatomy of the liver Liver scintigraphy The labelled colloid (200 MBq 99mTc-Fyton) is phagocyted by the Kuppfer-cells
Nuclear Oncology Applications
Nuclear Oncology Applications Michael G. Stabin Vanderbilt University Nashville, TN XX Congresso Brasileiro de Física Médica e Simpósio Internacional de Proteção Radiológica em Medicina 12 a 15/Ago/2015
Description MRI, TMJ C T Head Without Contrast C T Head With Contrast C T Head Without & With Contrast
s Requiring Prior Authorization for the Advanced Imaging 70336 MRI, TMJ 70450 C T Head Without Contrast 70460 C T Head With Contrast 70470 C T Head Without & With Contrast 70480 C T Orbit Without Contrast
Nuclear Medicine Technique I
Nuclear Medicine Technique I RAD 355 Lecture s Title: INTRODUCTION TO NUCLEAR MEDICINE Dr. Mohammed Emam Overview Introduction Imaging Principles Radiotherapy An Approach to Image Interpretation Following
From 2015/2016 Batch
Department of & Nuclear February 7, 2018 Medical Imaging Module 04 th Year 1 st and 2 nd Semesters From 2015/2016 Batch Topic Objectives Time Dept. T / L Activity Comments Understand the principles of
Radionuclide & Radiopharmaceuticals
Radionuclide & Radiopharmaceuticals 1. Generator & Reactors 2. Cyclotrons & PET tracer 3. Quality control 4. Renal 5. GIT 6. CNS & Psychiatrics 7. Tumor Diagnosis & Treatment 8. Bones & joints 9. Thyroid
NM-GGC-PROC-006 Nuclear Medicine Referral Criteria. NHS Greater Glasgow and Clyde
Referring Patients f Nuclear Medicine Procedures in Greater Glasgow and Clyde Introduction The Ionising Radiation (Medical Exposure) Regulations [IR(ME)R] 000 make it necessary f all investigations using
Nuclear Medicine in Oncology
Radiopharmaceuticals Nuclear Medicine in Oncology Practice Pharmaceutical Radionuc lide Function Tumor type Diphosphonates Tc-99m Osteoblast Bone tumor & metast. Ga-citrate Ga-67 Fe-analogue Bronchogenous
weighing risks against benefits ALARA principle appropriate activities (radiopharmaceutical doses)
weighing risks against benefits ALARA principle appropriate activities (radiopharmaceutical doses) based on EANM references adequate appointment method (patient booking system) Appropriate activities (doses)
Nuclear medicine in gastrointestinal system. Assoc. prof. V. Marković, MD, PhD Assoc. prof. A. Punda, MD, PhD A. Barić, MD, nucl. med. spec.
Nuclear medicine in gastrointestinal system Assoc. prof. V. Marković, MD, PhD Assoc. prof. A. Punda, MD, PhD A. Barić, MD, nucl. med. spec. Hepatobiliary imaging Hepatobiliary imaging is nuclear medicine
Florida Hospital Diagnostic Radiology Residency Nuclear Medicine Goals and Objectives Training Location: Orlando
Florida Hospital Diagnostic Radiology Residency Nuclear Medicine Goals and Objectives Training Location: Orlando Nuclear Medicine Curriculum I. Introduction The core of the Nuclear Medicine training is
Malignant Cardiac Tumors Rad-Path Correlation
Malignant Cardiac Tumors Rad-Path Correlation Vincent B. Ho, M.D., M.B.A. 1 Jean Jeudy, M.D. 2 Aletta Ann Frazier, M.D. 2 1 Uniformed Services University of the Health Sciences 2 University of Maryland
OTHER NON-CARDIAC USES OF Tc-99m CARDIAC AGENTS Tc-99m Sestamibi for parathyroid imaging, breast tumor imaging, and imaging of other malignant tumors.
DEFINITION OF CARDIAC RADIOPHARMACEUTICAL: A radioactive drug which, when administered for purpose of diagnosis of heart disease, typically elicits no physiological response from the patient. Even though
Nuclear Medicine Diagnosis
Anatomy : MRI Fonction : Nucl Med Nuclear Medicine Diagnosis Functional imaging = distribution of a (radio)- tracer in organs Each tracer is a SPY of a function, usually through a metabolic pathway flow
Radiopharmacy. Prof. Dr. Çetin ÖNSEL. CTF Nükleer Tıp Anabilim Dalı
Prof. Dr. Çetin ÖNSEL CTF Nükleer Tıp Anabilim Dalı What is Nuclear Medicine? Nuclear Medicine is the branch of medicine concerned with the use of radionuclides in the study and the diagnosis of diseases.
Hybrid Imaging SPECT/CT PET/CT PET/MRI. SNMMI Southwest Chapter Aaron C. Jessop, MD
Hybrid Imaging SPECT/CT PET/CT PET/MRI SNMMI Southwest Chapter 2014 Aaron C. Jessop, MD Assistant Professor, Department of Nuclear Medicine UT MD Anderson Cancer Center, Houston, Texas Complimentary role
Clinical Trials? John Buscombe
Clinical Trials? John Buscombe Introduc7on Look at the role of clinical trials in radionuclide therapy Understand some of the terms used in clinical trials Look at two recent examples Commercial trial
EXPOSURE FROM DIAGNOSTIC NUCLEAR MEDICINE PROCEDURES. 14 Victor Babes Street, RO-6600, Iasi, Romania
EXPOSURE FROM DIAGNOSTIC NUCLEAR MEDICINE PROCEDURES 1 O. Iacob, 1 C. Diaconescu, 2 R. Isac 1 Institute of Public Health- Iasi, Radiation Protection Department 14 Victor Babes Street, RO-6600, Iasi, Romania
Nuclear medicine in renal scarring
Paediatric NM General principles Need to image in a child friendly department Maybe use of play therapist to help explain the procedure Reduce activities as weight a proportion of 70kg adult with 10% minimum
Nuclear Medicine: Manuals. Nuclear Medicine. Nuclear imaging. Emission imaging: study types. Bone scintigraphy - technique
Nuclear Medicine - Unsealed radioactive preparations the tracer mixes with the patients body fluids on a molecular level (e.g. after intravenous injection) - 3 main fields: - In vitro : measuring concentrations
Gastrointestinal tract
Gastrointestinal tract Colloidal liver-spleen imaging Presented by: Jehad Felemban Introduction: To obtain better anatomic display of liver and spleen architecture, we use (CT Ultrasound). (Radionuclide
PATIENT DOSES DUE TO DIAGNOSTIC NUCLEAR MEDICINE EXAMINATIONS IN LITHUANIA
PATIENT DOSES DUE TO DIAGNOSTIC NUCLEAR MEDICINE EXAMINATIONS IN LITHUANIA Vaida Grigonienė, A. Čepulienė, F. Sakalauskas, J. Marcinkevičius, J. Žiliukas Kaunas, 2012 1 Radiation protection Efficient radiation
Outline. Lifetime Attributable Risk 10 mgy in 100,000 exposed persons (BEIR VII 2006) SPECT/CT and PET/CT Dosimetry
SPECT/CT and PET/CT Dosimetry Lifetime Attributable Risk 10 mgy in 100,000 exposed persons (BEIR VII 2006) All Solid Tumors Leukemia Frederic H. Fahey DSc Male Female Male Female Children s Hospital Boston
THE PARATHYROID GLAND THEORY AND NUCLEAR MEDICINE PRACTICE
THE PARATHYROID GLAND THEORY AND NUCLEAR MEDICINE PRACTICE George N. Sfakianakis MD Professor of Radiology and Pediatrics Director, Division of Nuclear Medicine UM/JMMC Miami FL October 2009 ENDONCRINE
Chapter 19: Radionuclide Therapy
Chapter 19: Radionuclide Therapy Slide set of 40 slides based on the chapter authored by G. Flux and Y. Du of the publication (ISBN 978 92 0 143810 2): Nuclear Medicine Physics: A Handbook for Teachers
Austin Radiological Association Nuclear Medicine Procedure THERAPY FOR THYROID CANCER (I-131 as Sodium Iodide)
Austin Radiological Association Nuclear Medicine Procedure THERAPY FOR THYROID CANCER (I-131 as Sodium Iodide) Overview Indications I-131 therapy for Thyroid Cancer, of the papillo-follicular type, is
Paediatrics. John Buscombe
Paediatrics John Buscombe Renal disease n Use of most radiopharmaceuticals limited as excreted via kidneys n However some role for infection specific studies in no-working kidneys Eg Infected polycystic
PHARMACEUTICALS IN MEDICAL IMAGING
PHARMACEUTICALS IN MEDICAL IMAGING Radiopaque Contrast Media Radiopharmaceuticals Enhancement Agents for Magnetic Resonance Imaging and Ultrasound MACMILLAN PUBLISHING CO., INC. New York COLLIER MACMILLAN
Case 4: Disseminated bone metastases from differentiated follicular thyroid cancer
Case 4: Disseminated bone metastases from differentiated follicular thyroid cancer Giuliano Mariani Regional Center of Nuclear Medicine, University of Pisa Medical School, Pisa (Italy) Disseminated bone
NUCLEAR MEDICINE APC TASK FORCE
NUCLEAR MEDICINE APC TASK FORCE Academy of Molecular Imaging American College of Nuclear Physicians American College of Radiology American Society of Nuclear Cardiology Council on Radionuclides and Radiopharmaceuticals,
COURSE OUTLINE Pathophysiology
Butler Community College Health, Education, and Public Services Division Denise LaKous Revised Spring 2014 Implemented Fall 2015 Textbook Update Fall 2015 COURSE OUTLINE Pathophysiology Course Description
SCINTIGRAPHY OF THE CENTRAL NERVOUS SYSTEM Part 1: Introduction and BBB studies
SCINTIGRAPHY OF THE CENTRAL NERVOUS SYSTEM Part 1: Introduction and BBB studies George N. Sfakianakis MD Professor of Radiology and Pediatrics Director, Division of Nuclear Medicine October 2009 FIRST
Nuclear medicine in oncology. 1. Diagnosis 2. Therapy
Nuclear medicine in oncology 1. Diagnosis 2. Therapy Diagnosis - Conventional methods - Nonspecific radiopharmaceuticals cumulating in tumours - Specific radiopharmaceuticals, receptor- and immunoscintigraphy
Nuclear Medicine Ordering Guide
Nuclear Medicine Ordering Guide The Children s (updated 02/21/11) Radiological Institute MUSCULOSKELETAL STUDIES Examples of symptoms / diagnoses / indications for exam Recommended Examination CPT Codes
Tumor Imaging in Nuclear Medicine: Current Status and
Tumor Imaging in Nuclear Medicine: Current Status and Future Prospects Bennett S. Greenspan, MD SNM MWM Albuquerque, NM January 30, 2010 Tumor Imaging Part I Current Status Current status agents that are
Nuclear medicine in endocrinology
Nuclear medicine in endocrinology Thyroid gland: anatomy, function, inflammation, Nuclear medicine in endocrinology tumor dignitiy Parathyroid gland: localisation Adrenal cortex: function Adrenal medulla:
Medical imaging X-ray, CT, MRI, scintigraphy, SPECT, PET Györgyi Műzes
Medical imaging X-ray, CT, MRI, scintigraphy, SPECT, PET Györgyi Műzes Semmelweis University, 2nd Dept. of Medicine Medical imaging: definition technical process of creating visual representations about
Itroduction to the Nuclear Medicine: biophysics and basic principles. Zámbó Katalin Department of Nuclear Medicine
Itroduction to the Nuclear Medicine: biophysics and basic principles Zámbó Katalin Department of Nuclear Medicine NUCLEAR MEDICINE Application of the radioactive isotopes in the diagnostics and in the
The Role of SPECT/ PET
Session 15: Imaging Heart Failure The Role of SPECT/ PET Albert Flotats, MD, FEBNM Hospital de la Santa Creu i Sant Pau, Barcelona Universitat Autònoma de Barcelona HF - Clinical Questions 1. Etiology?
Last Updated: 2/10/2017 Implementation date: 4/3/2017 Radiology & Cardiology Prior Authorization / Utilization Management Procedure List
Last Updated: 2/10/2017 Implementation date: 4/3/2017 Radiology & Cardiology Prior Authorization / Utilization Management Procedure List Deal Sheet Group Product Category CPT CPT Description 3D Imaging
Dose reduction has been a work in progress in pediatric
Pediatric Radiopharmaceutical Administered Doses: 2010 North American Consensus Guidelines Michael J. Gelfand 1, Marguerite T. Parisi 2, and S. Ted Treves 3 1 Section of Nuclear Medicine, Department of
A Doctor's Guide to Nuclear Medicine
A Doctor's Guide to Nuclear Medicine Definitions: Nuclear Medicine is a medical speciality that uses the nuclear properties of radioactive elements in diagnosis or therapy of diseases. The most visible
Population Collective Effective Dose from Nuclear Medicine procedures in Greece
Population Collective Effective Dose from Nuclear Medicine procedures in Greece S.Vogiatzi, M.Lambrinakou, A.Liossis, C.J.Hourdakis Greek Atomic Energy Commission www.eeae.gr Contents Introduction Materials
Le FDG dans l évaluation de la viabilité : Quelle place par rapport aux autres traceurs?
Le FDG dans l évaluation de la viabilité : Quelle place par rapport aux autres traceurs? Pierre-Yves MARIE, Médecine Nucléaire, CHU de Nancy PET Gated-SPECT MRI FDG imaging: effect of dietary status fasting
TW Hamilton, EP Ficaro, TA Mitchell, JN Kritzman, JR Corbett University of Michigan Health System, Ann Arbor, MI
Accuracy and Variability of of 3D-MSPECT for Estimating the Left Ventricular Ejection Fraction as as a Function of of Gating Frames and Reconstruction Filters TW Hamilton, EP Ficaro, TA Mitchell, JN Kritzman,
73725x2 MRA Pelvis Runoff (to ankle) CTA Abdomen with & without CTA Cardiac Brain without 70551
CT CT Myelogram MRI Abdomen without 74150 Cervical 62302 Abdomen / MRCP 74181 Abdomen with 74160 Thoracic 62303 Abdomen / MRCP with & without 74183 Abdomen with & without 74170 Lumbar 62304 Abdomen / Pelvis
Parathyroid Imaging What is best
Parathyroid Imaging What is best Mike Avison Bradford Why me? I m honoured to be asked to present this. There is no killer paper or text which clearly proves the best methodology. Bradford has performed
Indium-111 Zevalin Imaging
Indium-111 Zevalin Imaging Background: Most B lymphocytes (beyond the stem cell stage) contain a surface antigen called CD20. It is possible to kill these lymphocytes by injecting an antibody to CD20.
Part 7: Regulatory Issues and Quality Control. Part 1: Current NRC Regulations Related to Radiation Safety
Part 7: Regulatory Issues and Quality Control Part 1: Current NRC Regulations Related to Radiation Safety 1. Secretarial space, hallways, and certain other areas of a department must qualify as an UNRESTRICTED
NEW ASPECTS OF RADIONUCLIDE THERAPY OF BONE AND JOINT DISEASES
NEW ASPECTS OF RADIONUCLIDE THERAPY OF BONE AND JOINT DISEASES M.FISCHER Department of Nuclear Medicine, Klinikum Kassel, Kassel, Germany XA0102662 Abstract. Whereas in developing countries P-32 is widely
A 64 y.o. man presents to the hospital with persistent cough and hemoptysis. Fernando Mut Montevideo - Uruguay
A 64 y.o. man presents to the hospital with persistent cough and hemoptysis Fernando Mut Montevideo - Uruguay Teaching case Bone # 1 A 64 y.o. man presents to the hospital with persistent cough and hemoptysis.
PRODUCT CATALOGUE. A complete palette in Nuclear Medicine. Oncology. Cardiology. Neurology
PRODUCT CATALOGUE A complete palette in Nuclear Medicine Oncology Cardiology Neurology INTERNATIONAL CATALOGUEALOGUE This is a comprehensive list of all products. Some products may not be available in
Nuclear Cardiology Reimbursement. Todd Lamb, BS, AS, CNMT Clinical Operations Mgr Regions Hospital St. Paul, MN
Nuclear Cardiology Reimbursement Todd Lamb, BS, AS, CNMT Clinical Operations Mgr Regions Hospital St. Paul, MN Slides are not to be reproduced without the permission of the author Slides are not to be
Nuclear Medicine in the Diabetic Foot
26.11.2015, Uniklinik Balgrist Nuclear Medicine in the Diabetic Foot Martin Hüllner Nuklearmedizin und Neuroradiologie, USZ / UZH Outline A. Imaging modalities brief technical overview B. Nuclear medicine
Click here for Link to References: CMS Website HOPPS CY 2018 Final Rule. CMS Website HOPPS CY2018 Final Rule Updated November 2017.
Final Compared to 3Q 2017 Rates Medicare Hospital Outpatient Prospective Payment System HOPPS () Nuclear Cardiology Procedures, Radiopharmaceuticals, and Drugs Click here for Link to References: CMS Website
AN INTRODUCTION TO NUCLEAR MEDICINE
AN INTRODUCTION TO NUCLEAR MEDICINE WITH RESPECT TO THYROID DISORDERS By: B.Shafiei MD Nuclear Physician Taleghani Medical Center Radioactive: An element with Unstable Nucleus (Excess Energy), can achieve
RADIOMETABOLIC THERAPY!!
EXPLOITING NEW EVIDENCES OF DRUG- RADIATION INTERACTIONS IN CLINICS The role of radioactive drugs: from prostate cancer to lymphomas Dr. G. Simontacchi AOU Careggi - Firenze What if we could deliver radiation
Updated version
Indicator A D E FIAL 2015 Compared to FIAL 2016 s Medicare Hospital Outpatient Prospective System HOPPS (APC) uclear Medicine Procedures, Radiopharmaceuticals, and Drugs CY15 HOPPS Final Rule CY16 HOPPS
Austin Radiological Association Nuclear Medicine Procedure BONE MINERAL STUDY (Tc-99m-MDP, Tc-99m-HMDP)
Austin Radiological Association Nuclear Medicine Procedure BONE MINERAL STUDY (Tc-99m-MDP, Tc-99m-HMDP) Overview The Bone Mineral Study, with either Tc-99m-MDP or Tc-99m-HMDP, depicts the distribution
Austin Radiological Association Nuclear Medicine Procedure WHITE BLOOD CELL MIGRATION STUDY (In-111-WBCs, Tc-99m-HMPAO-WBCs)
Austin Radiological Association Nuclear Medicine Procedure WHITE BLOOD CELL MIGRATION STUDY (In-111-WBCs, Tc-99m-HMPAO-WBCs) Overview Indications The White Blood Cell Migration Study demonstrates the distribution
Imaging in Pediatric Thyroid disorders: US and Radionuclide imaging. Deepa R Biyyam, MD Attending Pediatric Radiologist
Imaging in Pediatric Thyroid disorders: US and Radionuclide imaging Deepa R Biyyam, MD Attending Pediatric Radiologist Imaging in Pediatric Thyroid disorders: Imaging modalities Outline ACR-SNM-SPR guidelines
Nuclear medicine in oncology. 1. Diagnosis 2. Therapy
Nuclear medicine in oncology 1. Diagnosis 2. Therapy Diagnosis - Conventional methods - Nonspecific radiopharmaceuticals cumulating in tumours - Specific radiopharmaceuticals (receptor- and immunoscintigraphy)
Establishment of Dose Reference Levels for Nuclear Medicine in Sudan
Open Journal of Radiology, 2016, 6, 258-263 http://www.scirp.org/journal/ojrad ISSN Online: 2164-3032 ISSN Print: 2164-3024 Establishment of Dose Reference Levels for Nuclear Medicine in Sudan Wadah M.
MEDICAL FACULTY DEPARTMENT OF PATHOPHYSIOLOGY QUESTION FOR ORAL PART OF EXAM MEDICAL STUDENTS
MEDICAL FACULTY DEPARTMENT OF PATHOPHYSIOLOGY QUESTION FOR ORAL PART OF EXAM MEDICAL STUDENTS GENERAL PART (1 question) 1. Health and disease as a dynamic process 2. Stages of the disease development 3.
New Horizons in radionuclide therapy. John Buscombe Royal Free Hospital
New Horizons in radionuclide therapy John Buscombe Royal Free Hospital Date for you diary Interested in Radionuclide imaging and therapy using antibodies and peptides IRIST 2008 Krakow Poland 18-21 June
Content Manual American Board of Nuclear Medicine
Content Manual American Board of Nuclear Medicine 2/11/2016 I. Basic Science A. Biochemistry, Molecular Biology and Pharmacology 1. Biochemistry 2. Cellular and Molecular Biology a. Optical b. Radionuclide
NUCLEAR CARDIOLOGY UPDATE
Nuclear Cardiology David K. Shelton, Jr., MD NUCLEAR CARDIOLOGY UPDATE No Conflicts. No Disclosures. No Smoking. David K. Shelton UCDMC Nuclear Cardiology Nuclear Cardiology Radionuclide Ventriculography
15 Annex - Energy 81. RULEBOOK ON APPLICATION OF IONISING RADIATION SOURCES IN MEDICINE
15 Annex - Energy 81. RULEBOOK ON APPLICATION OF IONISING RADIATION SOURCES IN MEDICINE RULEBOOK ON APPLICATION OF IONISING RADIATION SOURCES IN MEDICINE (Official Gazette of the Federal Republic of Yugoslavia
RADIONUCLIDE THERAPY FOR PALLIATION OF PAIN FROM BONY METASTASES
RADIONUCLIDE THERAPY FOR PALLIATION OF PAIN FROM BONY METASTASES Overview and Topics to Be Covered Reviews the use of radionuclide therapy in nuclear medicine for palliation of pain due to bony metastases.